Major furocoumarins in grapefruit juice I: Levels and urinary metabolite(s)

Food and Chemical Toxicology

Volumn 49, Issue 12, 2011, Pages 3224-3231

  Messer, Anastasia ^a   Nieborowski, Anna ^a   Strasser, Christian ^a   Lohr, Christiane ^a   Schrenk, Dieter ^a  

^a Rheinland Pfälzische Technische Universität Kaiserslautern Landau   (Germany)

Author keywords

Furocoumarins; Grapefruit juice; Metabolites; Phototoxic; Urinary excretion

Indexed keywords

6',7' DIHYDROXYBERGAMOTTIN; BERGAMOTTIN; BERGAPTOL; FUROCOUMARIN DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; FEMALE; FOOD ANALYSIS; FOOD COMPOSITION; GRAPEFRUIT JUICE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; METABOLITE; NORMAL HUMAN; STRUCTURE ANALYSIS; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ADULT; BEVERAGES; CITRUS PARADISI; FEMALE; HUMANS; LIMIT OF DETECTION; MALE; PSORALENS; YOUNG ADULT;

CITRUS X PARADISI;

EID: 80054846762     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2011.09.005     Document Type: Article

References (43)

1. Aubin F., Humbert P., Agache P. Effects of a new psoralen, 5-geranoxypsoralen, plus UVA radiation on murine ATPase positive Langerhans cells. J. Dermatol. Sci. 1994, 7:176-184.
2. Brickl R., Schmid J., Koss F.W. Pharmacokinetics and pharmacodynamics of psoralens after oral administration: considerations and conclusions. Nat. Cancer Inst. Monogr. 1984, 66:63-67.
3. COT, 1996. Toxicity, Mutagenicity and Carcinogenicity Report 1996. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. http://www.archive.official-documents.co.uk/document/doh/toxicity/chap-1c.htm.
4. De Castro W.V., Mertens-Talcott S., Rubner A., Butterweck V., Derendorf H. Variation of flavonoids and furanocoumarins in grapefruit juices: a potential source of variability in grapefruit juice-drug interaction studies. J. Agric. Food Chem. 2006, 54:249-255.
5. Edwards D.J., Bellevue F.H., Woster P.M. Identification of 6',7'-dihydroxy-bergamottin, a cytochrome P450 inhibitor, in grapefruit juice. Drug Metabol. Disp. 1996, 24:1287-1290.
6. Ehrsson H., Wallin I., Ros A.M., Eksborg S., Berg M. Food-induced increase in bioavailability of 5-methoxypsoralen. Eur. J. Clin. Pharmacol. 1994, 46:375-377.
7. Feger W., Brandauer H., Gabris P., Ziegler H. Nonvolatiles of commercial lime and grapefruit oils separated by high-speed countercurrent chromatography. J. Agric. Food Chem. 2006, 54:2242-2252.
8. Frérot E., Decorzant E. Quantification of total furocumarins in citrus oil by HPLC couples with UV, fluorescence, and mass detection. J. Agric. Food Chem. 2004, 52:6879-6886.
9. Fukuda K., Guo L., Ohashi N., Yoshikawa M., Yamazoe Y. Amounts and variation in grapefruit juice of the main components causing grapefruit-drug interaction. J. Chromat. B Biomed. Sci. Applic. 2000, 741:195-203.
10. Girennavar B., Jayaprakasha G.K., Patil B.S. Potent inhibition of human cytochrome P450 3A4, 2D6, and 2C9 isoenzymes by grapefruit juice and its furocoumarins. J. Food Sci. 2007, 72:C417-C421.
11. Gorgus E., Lohr C., Raquet N., Guth S., Schrenk D. Limettin and furocoumarins in beverages containing citrus juices or extracts. Food Chem. Toxicol. 2010, 48:93-98.
12. Guo L.Q., Yamazoe Y. Inhibition of cytochrome P450 by furanocoumarins in grapefruit juice and herbal medicines. Acta Pharmacol. Sin. 2004, 25:129-136.
13. He K., Iyer K.R., Hayes R.N., Sinz M.W., Woolf T.F., Hollenberg P.F. Inactivation of cytochrome P450 3A4 by bergamottin, a component of grapefruit juice. Chem. Res Toxicol. 1998, 11:252-259.
14. Ho P.C., Saville D.J., Coville P.F., Wanwimolruk S. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products. Pharm. Acta Helvet. 2000, 74:379-385.
15. IARC, 1987. 8-Methxypsoralen (methoxsalen) plus ultraviolet radiation. International Agency for Research on Cancer Monographs on the Evaluation of the Carcinogenic Risk of Chemicals in Man. Suppl. 7, 261.
16. John B.A., Chasseaud L.F., Wood S.G., Forlot P. Metabolism of the anti-psoriatic agent 5 methoxypsoralen in humans: comparison with rat and dog. Xenobiotica 1992, 22:1339-1351.
17. Kent U.M., Lin H.L., Noon K.R., Harris D.L., Hollenberg P.F. Metabolism of bergamottin by cytochromes P450 2B6 and 3A5. J. Pharmacol. Exp. Ther. 2006, 318:992-1005.
18. Lee Y.S., Reidenberg M.M. A method for measuring naringenin in biological fluids and its disposition from grapefruit juice by man. Pharmacology 1998, 56:314-317.
19. Leiter U., Garbe C. Epidemiology of melanoma and non-melanoma skin cancer- the role of sunlight. Adv. Exp. Med. Biol. 2008, 624:89-103.
20. Ljunggren B. Severe phototoxic burn following celery ingestion. Arch. Dermatol. 1990, 126:1334-1336.
21. Lohr C., Raquet N., Schrenk D. Application of the concept of relative photomutagenic potencies to selected furocoumarins in V79 cells. Tox. In Vitro 2010, 24:558-566.
22. Manthey J.A., Buslig B.S. Distribution of furanocoumarins in grapefruit juice fractions. J. Agric. Food Chem. 2005, 53:5158-5163.
23. Mays D.C., Rogers S.L., Guiler R.C., Sharp D.E., Hecht S.G., Staubus A.E., Gerber N. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites. J. Pharmacol. Exp. Ther. 1986, 236:364-373.
24. Mays D.C., Hilliard J.B., Wong D.D., Gerber N. Activation of 8-methoxypsoralen by cytochrome P-450. Enzyme kinetics of covalent binding and influence of inhibitors and inducers of drug metabolism. Biochem. Pharmacol. 1989, 38:1647-1655.
25. Mohri K., Uesawa Y. Effects of furanocoumarin derivatives in grapefruit juice on nifedipine pharmacokinetics in rats. Pharm. Res. 2001, 18:177-182.
26. Murray R.D.H., Mendes J., Brown S.A. The Natural Coumarins: Occurrence, Chemistry and Biochemistry 1982, Wiley and Son, New York.
27. Nigg H.N., Nordby H.E., Beier R.C., Dillman A., Macias C., Hansen R.C. Phototoxic coumarins in limes. Food Chem. Toxicol. 1993, 31:331-335.
28. Ramaswamy S. Psoralens in foods. Ind. Food Packer 1975, 8:37-46.
29. Raquet N., Schrenk D. Relative photomutagenicity of furocoumarins and limettin in the hypoxanthine phosphoribosyl transferase assay in V79 cells. Chem. Res. Toxicol. 2009, 22:1639-1647.
30. Sakamaki N., Nakazato M., Matsumoto K.H., Hirata K., Ushiyuma H. Contents of furanocoumarins in grapefruit juice and health foods. Food Hyg. Safety Sci. (Shokuhin Eiseigaku Zasshi) 2008, 49:326-331.
31. Schlatter J., Zimmerli B., Dick R., Panizzon R., Schlatter C. Dietary intake and risk assessment of phototoxic furocoumarins in humans. Food Chem. Toxicol. 1991, 29:523-530.
32. Schmid J., Prox A., Reuter A., Zipp H., Koss F.W. The metabolism of 8-methoxypsoralen in man. Europ. J. Drug Metab. Pharmacokin. 1980, 5:81-92.
33. Shephard S.E., Langguth P., Panizzon R.G. Pharmacokinetic behaviour of sublingually administered 8-methoxypsoralen for PUVA therapy. Photoderm. Photoimmunol. Photomed. 2001, 17:11-21.
34. Toxicological Assessment of Furocoumarins in Foodstuffs. DFG Senate Commission on Food Safety 2006, SKLM, Kaiserslautern, Germany.
35. Update of the Toxicological Assessment of Furanocoumarins in Foodstuffs. DFG Senate Commission on Food Safety 2010, SKLM, Kaiserslautern, Germany.
36. Sontag G., Franke E., Nikiforov A. Identifizierung von Bergaptol in Citrusfrüchten. Fres. Z. Anal. Chem. 1983, 314:572-576.
37. Stern R.S. The risk of melanoma in association with long-term exposure to PUVA. J. Amer. Acad. Dermatol. 2001, 44:755-761.
38. Stern R.S., Liebmann E.J., Vakeva L. Oral psoralen and ultraviolet - A light (PUVA) treatment of psoriasis and persistent risk of nonmelanoma skin cancer. PUVA follow-up study. J. Nat. Cancer Inst. 1998, 90:1278-1284.
39. Tassaneeyakul W., Guo L.-Q., Fukuda K., Ohta T., Yamazoe Y. Inhibition selectivity of grapefruit juice components on human cytochrome P450. Arch. Biochem. Biophys. 2000, 378:356-363.
40. Uesawa Y., Mohri K. The use of heat treatment to eliminate drug interactions due to grapefruit juice. Biol. Pharmacol. Bull. 2006, 29:2274-2278.
41. Wagstaff D.J. Dietary exposure to furocoumarins. Reg. Tox. Pharm. 1991, 14:261-272.
42. Wanwimolruk S., Marquez P.V. Variations in content of active ingredients causing drug interactions in grapefruit juice products sold in California. Drug Metab. Drug Interact. 2006, 21:233-243.
43. Weber I.C., Davis C.P., Greeson D.M. Phytophotodermatitis: the other " lime" disease. J. Emerg. Med. 1999, 17:235-237.